SLOUGH (dpa-AFX) - Consumer goods giant Reckitt Benckiser Group Plc. (RBGPF.PK, RB.L) Thursday said it will invest 100 million pounds in its consumer health R&D operations with the creation of a state of the art Centre of Scientific Excellence to be based in the UK.
According to the firm, the decision underlines its commitment to growth across its consumer health and hygiene brands, providing trusted, innovative solutions that help people live healthier lives.
One of six major RB R&D facilities worldwide, the new UK centre will become the global technical innovation hub for products such as Nurofen and Strepsils, the company said.
The project will include the development of a major new building on the site equipped with state of the art consumer health laboratory facilities.
Copyright RTT News/dpa-AFX